HomeNewsBusinessPersonal FinanceTerm insurance premiums are set to rise from December: Here’s what you should do

Term insurance premiums are set to rise from December: Here’s what you should do

Once you buy a policy, the term rates will remain the same throughout the tenure, so it makes sense to lock into lower rates now

November 29, 2021 / 14:30 IST
Story continues below Advertisement
Representative image
Representative image

Pure protection term insurance premiums are set to see a spike yet again. This time, the jump is likely to be in the range of 25-45 percent on the back of rising re-insurance rates in the global market, say industry watchers. Several life insurance companies have raised their premiums since the COVID-19 outbreak last year due to concerns over high mortality rates. This time round, too, the pandemic-driven higher death rate is the culprit.

High reinsurance rates will push up Indian term premiums

Story continues below Advertisement

International reinsurer Munich Re has reportedly intimated life insurers in India regarding the impending price increase in December. “Some may pass on part of the rate hike, while others could absorb a part of the increase or negotiate with their reinsurers to reduce the extent of hike. Some insurers have already raised rates,” says a top insurance aggregator official who spoke on the condition of anonymity.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show